Neurocrine down on indiplon delay

NBIX was off $3.31 (30%) to $7.72 on Friday after disclosing in its third quarter earnings that it is delaying resubmission of

Read the full 222 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE